Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples